{"nctId":"NCT02446990","briefTitle":"Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure","startDateStruct":{"date":"2009-09"},"conditions":["Coronary Artery Disease"],"count":19102,"armGroups":[{"label":"Ivabradine","type":"EXPERIMENTAL","interventionNames":["Drug: Ivabradine"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Ivabradine","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Evidence of coronary artery disease\n* Sinus rhythm and resting heart rate equal or higher than 70 bpm\n\nExclusion Criteria:\n\n* Unstable cardiovascular condition\n* Known hypersensitivity to ivabradine or current treatment with marketed ivabradine","healthyVolunteers":false,"sex":"ALL","minimumAge":"55 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Primary Composite Endpoint","description":"First event among cardiovascular death or non-fatal myocardial infarction","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"654","spread":null},{"groupId":"OG001","value":"611","spread":null}]}]}]},{"type":"SECONDARY","title":"All-cause Mortality","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"485","spread":null},{"groupId":"OG001","value":"458","spread":null}]}]}]},{"type":"SECONDARY","title":"Cardiovascular Mortality","description":"Component of the primary composite endpoint","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"329","spread":null},{"groupId":"OG001","value":"301","spread":null}]}]}]},{"type":"SECONDARY","title":"Coronary Mortality","description":"Coronary mortality including sudden death of unknown cause, death from myocardial infarction, death from heart failure, death from coronary artery procedure, presumed arrhythmic death","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"263","spread":null},{"groupId":"OG001","value":"249","spread":null}]}]}]},{"type":"SECONDARY","title":"Fatal Myocardial Infarction","description":"Non-composite secondary endpoint","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"51","spread":null},{"groupId":"OG001","value":"38","spread":null}]}]}]},{"type":"SECONDARY","title":"Non-fatal Myocardial Infarction","description":"Component of the primary composite endpoint","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"351","spread":null},{"groupId":"OG001","value":"339","spread":null}]}]}]},{"type":"SECONDARY","title":"Elective Coronary Revascularisation","description":"Non-composite secondary endpoint","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"270","spread":null},{"groupId":"OG001","value":"305","spread":null}]}]}]},{"type":"SECONDARY","title":"Coronary Revascularisation (Elective or Not)","description":"Non-composite secondary endpoint","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"562","spread":null},{"groupId":"OG001","value":"564","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Composite Endpoint","description":"Fatal or non-fatal myocardial infarction","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"392","spread":null},{"groupId":"OG001","value":"372","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Composite Endpoint","description":"Fatal or non-fatal myocardial infarction, coronary revascularisation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"718","spread":null},{"groupId":"OG001","value":"739","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Composite Endpoint","description":"Fatal or non-fatal myocardial infarction, coronary revascularisation, unstable angina","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"766","spread":null},{"groupId":"OG001","value":"782","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Composite Endpoint","description":"Cardiovascular death, non-fatal myocardial infarction, non-fatal stroke","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"774","spread":null},{"groupId":"OG001","value":"731","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Composite Endpoint","description":"Coronary death, non-fatal myocardial infarction","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"590","spread":null},{"groupId":"OG001","value":"562","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Composite Endpoint","description":"Non-fatal myocardial infarction, coronary revascularisation, unstable angina","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"734","spread":null},{"groupId":"OG001","value":"759","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3379,"n":9539},"commonTop":["Hypertension","Heart rate decreased","Angina pectoris","Ventricular extrasystoles","Photopsia"]}}}